 |
diaDexus, Inc. Reports 2012 First Quarter Financial Results
May 8, 2012
|
22.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 8, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the first quarter of 2012.
Total revenues for the first quarter of 2012 were $4.9 million, a 4...
|
|
diaDexus, Inc. to Host Webcast May 8, 2012 on 2012 First Quarter Financial Results
May 1, 2012
|
11.4 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 1, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products, today announced that it will host a webcast on Tuesday, May 8 at 4:15 PM EDT (1:15 PM PDT) to discuss its 2012 first quarter r...
|
|
New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
Apr 26, 2012
|
17.1 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., April 26, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the inclusion of its vascular-specific inflammatory marker Lp-PLA2 in the American Association of Clinical Endocrinologis...
|
|
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
Mar 19, 2012
|
18.5 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2) Activity. The PLAC® Test for Lp-PLA(2) Activity is CE-m...
|
|
diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
Mar 15, 2012
|
24.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 15, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the 2011 fourth quarter and year-end.
Fourth quarter 2011
Total revenues for the 2011 fourth...
|
|
diaDexus Launches PLAC® Test for Lp-PLA(2) Activity in Europe
Mar 5, 2012
|
16.5 KB |
|
| |
SOUTH SAN FRANCISCO, March 5, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC® Test for Lp-PLA(2) Activity in Europe. The PLAC Activity test will be sold in Eu...
|
|
diaDexus, Inc. to Host Webcast March 15, 2012 on 2011 Fourth Quarter and Year-End Financial Results
Mar 1, 2012
|
11.5 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 1, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that it will host a webcast on Thursday, March 15 at 4:15 P...
|
|
diaDexus, Inc. Names Jean-Frederic Viret, Ph.D. Chief Financial Officer
Jan 18, 2012
|
15.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Jan. 18, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced the appointment of Jean-Frederic Viret, Ph.D. as its Chief Financial Officer, effective February 1,...
|
|
diaDexus, Inc. Pre-Announces 2011 Q4, YE Revenue and 2012 Guidance
Jan 9, 2012
|
15.1 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced preliminary Q4 2011 revenues of approximately $4.9 million, up 48% from the prior year's fourth quart...
|
|
diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
Dec 5, 2011
|
11.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Dec. 5, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at the Canaccord Genuity 6th Annual Cardiov...
|
|
diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
Nov 9, 2011
|
23.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Nov. 9, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2011.
Total reven...
|
|
diaDexus, Inc. to Host 3Q Results Webcast Wednesday, November 9, 2011
Nov 3, 2011
|
11.4 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Nov. 3, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that it will host a webcast on Wednesday, November 9 at 4:30 PM...
|
|
diaDexus, Inc. Achieves ISO-13485 Certification
Oct 6, 2011
|
13.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Oct. 6, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that the company has received its Certificate of Registration o...
|
|
diaDexus Appoints New CEO Brian E. Ward, Ph.D. and New CBO Michael Richey
Sep 26, 2011
|
17.7 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced the Board of Directors' appointment of a new chief executive ...
|
|
diaDexus to Present at the RW Baird 2011 Health Care Conference
Sep 1, 2011
|
11.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at Baird's 2011 Health Care Conference ...
|
|
diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter
Aug 15, 2011
|
23.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the second quarter of 2011.
Total rev...
|
|
diaDexus, Inc. to Host 2Q Results Webcast Monday, August 15, 2011
Aug 10, 2011
|
11.4 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Aug. 10, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that it will host a webcast on Monday, August 15 at 4:30 PM ED...
|
|
diaDexus Preannounces Strong Second Quarter Revenues
Jun 29, 2011
|
17.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., June 29, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that it expects to report strong revenue growth for the 2011 s...
|
|
diaDexus, Inc. Reports 2011 First Quarter Financial Results
May 16, 2011
|
22.9 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 16, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the first quarter of 2011.
Total reven...
|
|
diaDexus, Inc. Reports 2010 Fourth Quarter and Year-End Financial Results
Mar 21, 2011
|
25.3 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 21, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board:DDXS.ob - ...
|
|
|
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz